Abstract

Preview

The AZD1222 vaccine (Astrazeneca, Cambridge, UK) is effective and safe against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1. In real-life experience, cases of vaccine-induced thrombocytopenia and thrombosis (VITT) have been described, with associated high morbidity and mortality rates. Thrombocytopenia and thrombosis in unusual venous sites are the common clinical presentation, but arterial thrombosis has also been described2,3. Some treatment recommendations have been published4. Plasma exchange (PE) has recently been reported to be effective in three patients5. We discuss the case of a patient successfully treated with PE after a severe VITT with atypical arterial involvement.

References

Downloads

Authors

Carlos J. de Miguel-Sanchez Vascular Neurology Section and Stroke Center, Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Miguel Arguello-Tomas Haematology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain; 3Nephrology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spai

Gloria Perez-Rus Haematology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain; 3Nephrology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Pilar Vazquez-Allen Vascular Neurology Section and Stroke Center, Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Antonia G. Mijaylova-Antonova Nephrology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Fernando Anaya Nephrology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Miguel Lopez-Esteban Haematology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Jose Luis Diez-Martin Haematology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Antonio Carmelo Gil-Nuñez Vascular Neurology Section and Stroke Center, Neurology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

Cristina Pascual-Izquierdo Haematology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain

  • Abstract viewed - 819 times
  • PDF downloaded - 88 times